[1] The 11th Revision of the International Classification of Diseases (ICD-11)[S/OL]. World Health Organization, 2018. https://icd.who.int/browse11/l-m/en. [2] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. [3] Ghi MG, Paccagnella A, Ferrari D, et al.Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial[J]. Ann Oncol, 2017, 28(9):2206-2212. [4] Zhong LP, Zhang CP, Ren GX, et al.Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma[J]. J Clin Oncol, 2013, 31(6):744-51. [5] O'Reilly MA, Hynynen K. Emerging non-cancer applications of therapeutic ultrasound[J]. Int J Hyperthermia ,2015, 31(3): 310-318. [6] Verhaart RF, Fortunati V, Verduijn GM, et al.CT-based patient modeling for head and neck hyperthermia treatment planning: manual versus automatic normal-tissue-segmentation[J]. Radiother Oncol, 2014, 111(1): 158-163. [7] Falk MH, Issels RD.Hyperthermia in oncology[J]. Int J Hyperthermia, 2001, 17(1):1-18. [8] Feyerabend T, Steeves R, Wiedemann GJ, et al.Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies[J]. Oncol, 1996, 53(3):214-220. [9] Manaf NA, Aziz MN, Ridzuan DS, et al.Feasibility of A-mode ultrasound attenuation as a monitoring method of local hyperthermia treatment[J]. Med Biol Eng Comput, 2016, 54(6): 967-981. [10] Takahashi I, Emi Y, Hasuda S, et al.Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors[J]. Surgery, 2002, 131(1 Suppl):S78-84. [11] Yunoki T, Kariya A, Kondo T, et al.The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells[J]. Cancer Lett, 2013, 335(1): 52-57. [12] Zhao J, Wang S, Liu N, et al.Correlation between the expression of Id-1 and hyperthermia-associated molecules in oral squamous cell carcinoma[J]. J Clin Pathol, 2013, 66(9): 758-763. [13] Bai Z, Shi Y, Wang J, et al.Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer[J]. Oncotarget, 2017, 8(2): 3591-3599. [14] Wang H, Mao L, Zhang T, et al.Altered expression of TIM-3, LAG-3, IDO, PD-L1, and CTLA-4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients[J]. J Oral Pathol Med, 2019, 48(8):669-676. [15] Ju H, Mao L, Zhang L, et al.Ultrasound hyperthermia enhances chemo-sensitivity in oral squamous cell carcinoma by TRIF-mediated pathway[J]. J Oral Pathol Med, 2018, 47(10): 964-971. [16] Ren G, Jv H, Tian Z, et al.Ultrasound hyperthermia induces apoptosis in head and neck squamous cell carcinoma: An in vitro study[J]. Med Oral Pathol Oral Cir Bucal, 2017, 22(3): e289-e296. [17] Amichetti M, Graiff C, Fellin G, et al.Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study[J]. Int J Radiat Oncol Biol Phys, 1993, 26(5):801-807. [18] Nagashima K, Takagi R, Hoshina H.Effect of local hyperthermia on metastases in oral squamous cell carcinoma[J]. Int J Oral Maxillofac Surg, 2002, 31(1):84-89. [19] 任国欣, 沈国峰, 陈亚珠, 等.晚期口腔颌面部恶性肿瘤超声热化疗的Ⅰ/Ⅱ期临床研究[J].临床肿瘤学杂志, 2011,16(3):244-248. [20] 闫向勇,刘文超.热疗在肿瘤治疗中的研究进展[J].世界中西医结合杂志,2014,9(2):213-216. [21] Ettinger KS, Ganry L, Fernandes RP.Oral cavity cancer[J]. Oral Maxillofac Surg Clin North Am, 2019, 31(1):13-29. [22] Schwartz LH, Seymour L, Litière S, et al.RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group[J]. Eur J Cancer, 2016, 62:138-145. [23] 侯会珍. 恶性肿瘤热疗致皮肤烫伤的原因与预防[A]//河南省护理学会.河南省肿瘤全科护理学术交流会议资料汇编[C].郑州:河南省护理学会,2005:233-234. [24] 皋文君,刘砚燕,袁长蓉.国际肿瘤化疗药物不良反应评价系统-通用不良反应术语标准4.0版[J].肿瘤, 2012, 32(2):142-144. [25] 任国欣,郭伟.局部热疗在头颈癌综合治疗中的应用[J].中国口腔颌面外科杂志, 2004, 2(1):60-63. [26] Falchook AD, Green R, Knowles ME, et al.Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer[J]. JAMA Otolaryngol Head Neck Surg, 2016, 142(6):517-523. |